About
Gals Bio is pioneering a new category in women’s health and wellness called Fem-Wearables. By leveraging the unique vaginal environment and integrating AI-powered analysis, we provide personalized, early, and accessible home health solutions that are accurate, affordable, and designed for early-stage detection. These solutions include rapid screening, monitoring, and therapeutic care for women’s health needs.
Tulipon our first device enables clean collection of vaginal secretions for cancer screening. Women of any age with abnormal bleeding, BRCA mutations, or high cancer risk can use Tulipon for up to 12 hours. Its liquid-lock mechanism preserves the sample, which is then sent to a lab for AI-powered liquid biopsy analysis. Tulipon minimizes human interference, preventing errors and contamination. Its absorbent-free design ensures access to all fluids and tissue secretions, empowering early detection, convenience, and proactive reproductive health diagnostics.
Funding history · 2 rounds · $2.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Gals Bio's primary focus in the healthcare sector?
- Gals Bio focuses on pioneering Fem-Wearables, a new category in women's health and wellness, by integrating AI-powered analysis with the vaginal environment to provide personalized home health solutions.
- What is Gals Bio's flagship product and its purpose?
- Gals Bio's flagship product is Tulipon, a device designed for the clean collection of vaginal secretions for cancer screening. It can be used for up to 12 hours and its liquid-lock mechanism preserves samples for AI-powered liquid biopsy analysis.
- When was Gals Bio founded?
- Gals Bio was founded in October 2015.
- What is the total amount of funding Gals Bio has raised?
- Gals Bio has raised a total of $1,963,000 across its funding rounds. For a full financing history, please refer to startupim.
- When did Gals Bio complete its Pre-Seed funding round and who was an investor?
- Gals Bio completed a Pre-Seed funding round in April 2016, with AH trust as an investor.
- When was Gals Bio's most recent funding round, and what type of round was it?
- Gals Bio's most recent funding round was an Equity crowdfunding round in January 2022.
- How many employees does Gals Bio currently have?
- Gals Bio currently has 6 employees.
- Who is a founder of Gals Bio?
- Hilla Shaviv is a founder of Gals Bio.
- What is the current product stage of Gals Bio's offerings?
- Gals Bio's product is currently in the clinical trial stage.
- Has Gals Bio been granted any patents?
- Yes, Gals Bio has been granted one patent.